UK markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.83+1.52 (+7.48%)
As of 2:50PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 53.45B
Enterprise value 33.04B
Trailing P/E N/A
Forward P/E 117.06
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1,322.97
Price/book (mrq)17.29
Enterprise value/revenue 31,166.51
Enterprise value/EBITDA 6-29.99

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3703.16%
S&P500 52-week change 314.65%
52-week high 333.79
52-week low 31.92
50-day moving average 322.54
200-day moving average 312.23

Share statistics

Avg vol (3-month) 335.71M
Avg vol (10-day) 321.7M
Shares outstanding 5158.1M
Float 154.75M
% held by insiders 12.69%
% held by institutions 129.41%
Shares short (14 Jul 2020) 429.6M
Short ratio (14 Jul 2020) 40.51
Short % of float (14 Jul 2020) 419.13%
Short % of shares outstanding (14 Jul 2020) 418.72%
Shares short (prior month 14 Jun 2020) 425.78M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 Jun 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020


Profit margin 0.00%
Operating margin (ttm)-4,058.78%

Management effectiveness

Return on assets (ttm)-24.97%
Return on equity (ttm)-92.55%

Income statement

Revenue (ttm)2.61M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-53.10%
Gross profit (ttm)-82.01M
EBITDA -101.49M
Net income avi to common (ttm)-122.68M
Diluted EPS (ttm)-1.16
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)270M
Total cash per share (mrq)1.71
Total debt (mrq)98.52M
Total debt/equity (mrq)52.45
Current ratio (mrq)8.53
Book value per share (mrq)1.26

Cash flow statement

Operating cash flow (ttm)-90.85M
Levered free cash flow (ttm)-50.01M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more